IBNSINA PHARMA CO SAE EGX:ISPH:
IBNSINA PHARMA Q3 CONSOL NET PROFIT ATTRIBUTABLE EGP 271 MILLION
IBNSINA PHARMA Q3 CONSOL NET SALES EGP 20.35 BILLION
Ibnsina Pharma Q3 Consol Profit EGP 271 Million
Story so far
Earlier from Ibnsina Pharma
- SNG: Ibnsina Pharma leads non-pharma product distribution in Egyptian pharmacies in 9 months
- SNG: Egypt: Ibnsina Pharma to disburse $0.0033/share cash dividend in October
- Ibnsina Pharma FY Dividend Per Share EGP 0.16
- SNG: Ibnsina Pharma leads Egypt’s pharmaceutical distribution market with 31.1% share in H1 2025
- Ibnsina Pharma Q2 Consol Profit EGP 206.9 Million
Later from Ibnsina Pharma
- SNG: Egypt: Ibnsina Pharma’s consolidated profits surge 62.32% YoY in 9 months
- ZAWYA-SNG: Egypt: Ibnsina Pharma exits EGP $22.5mln financial leasing contracts
- Ibnsina Pharma Gets EGP 1.3 Bln Loan From EBRD To Finance Green Warehouse
- ZAWYA-SNG: Egypt: EBRD provides $27.6mln financing to Ibnsina Pharma for new warehouse
- Gulf stocks end lower on weak oil prices; Saudi leads decline
Follow Ibnsina Pharma into a list and get an email when it puts out news.
Follow Ibnsina Pharma